F02H6.7

Caenorhabditis elegans

Is affected by hpl-2; csr-1; and rsd-2 based on tiling array and RNA-seq studies.

K04G11.3

Caenorhabditis elegans

Enriched in CANL; intestine; rectum; and uterine seam cell based on tiling array; RNA-seq; single-cell RNA-seq; and microarray studies. Is affected by several genes including cyc-1; nuo-6; and atfs-1 based on microarray and RNA-seq studies. Is affected by six chemicals including stavudine; Zidovudine; and paraquat based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: RSD-2 N-terminal domain and RSD-2, N-terminal.

F52G2.3

Caenorhabditis elegans

Enriched in several structures, including ABaraapapaa; RID; body wall musculature; head mesodermal cell; and mechanosensory neurons based on microarray; tiling array; RNA-seq; and single-cell RNA-seq studies. Is affected by several genes including cua-1; atfs-1; and rsr-2 based on microarray and RNA-seq studies. Is affected by twelve chemicals including Alovudine; stavudine; and Psoralens based on RNA-seq and microarray studies. Is predicted to encode a protein with the following domains: RSD-2 N-terminal domain; RSD-2, N-terminal; and Phosphorylation site.

fbxa-178

Caenorhabditis elegans

Enriched in germ line based on RNA-seq studies. Is affected by several genes including nuo-6; atfs-1; and rsd-2 based on microarray and RNA-seq studies. Is affected by five chemicals including rotenone; cholesterol; and paraquat based on RNA-seq and microarray studies.

clec-177

Caenorhabditis elegans

Is affected by rsr-2; rsd-2; and sir-2.1 based on tiling array; RNA-seq; and microarray studies. Is predicted to encode a protein with the following domains: PAN-3 domain and PAN-like domain.

T08B6.2

Caenorhabditis elegans

Enriched in intestine based on tiling array and RNA-seq studies. Is affected by several genes including atfs-1; etr-1; and rsd-2 based on tiling array; microarray; and RNA-seq studies. Is affected by four chemicals including multi-walled carbon nanotube; paraquat; and resveratrol based on RNA-seq and microarray studies.

Y53F4B.16

Caenorhabditis elegans

Enriched in ABplpappaa; OLQDL; OLQDR; OLQVL; and OLQVR based on single-cell RNA-seq studies. Is affected by several genes including rsd-2; mrps-5; and clk-1 based on microarray and RNA-seq studies. Is affected by six chemicals including multi-walled carbon nanotube; Doxycycline; and dafa#1 based on RNA-seq and microarray studies.

C34C12.9

Caenorhabditis elegans

Enriched in PVT; body wall muscle cell; and head mesodermal cell based on tiling array; RNA-seq; and single-cell RNA-seq studies. Is affected by several genes including etr-1; rsd-2; and hsf-1 based on RNA-seq and microarray studies. Is affected by nine chemicals including Tunicamycin; Alovudine; and stavudine based on microarray and RNA-seq studies.

F52C6.14

Caenorhabditis elegans

Enriched in germ line and neurons based on RNA-seq studies. Is affected by several genes including mter-4; csr-1; and rsd-2 based on RNA-seq studies. Is affected by eight chemicals including aldicarb; multi-walled carbon nanotube; and Alovudine based on microarray and RNA-seq studies.

K02E7.12

Caenorhabditis elegans

Enriched in body wall muscle cell; body wall musculature; coelomocyte; and somatic gonad precursor based on tiling array; RNA-seq; and microarray studies. Is affected by several genes including etr-1; rsd-2; and lsm-1 based on RNA-seq and microarray studies. Is affected by five chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.